Andrew Barnell

Decode Health, Inc. is an American US-based health-tech company that provides a data platform to accelerate precision medicine and improve the efficiency of pharma research and development using AI and machine learning. The private company has partnered with leading research partners, diagnostic and technology companies to support pharma R & D. The company's goal is to deliver on the promise of precision medicine by connecting data and providing mature, scalable data operations and analytics expertise.

Part of Bioporto A/S, Bioporto Diagnostics A/S is a Danish company that engages in research and experimental development on biotechnology. The company is based in Gentofte, Denmark. Peter Morch Eriksen has been the CEO of the company since 2013.

Breathe BioMedical, Inc. engages in the development of breath tests to detect early-state breast cancer. Its products include breath samplers and spectrometers. The company was founded by John Cormier on April 1, 2005 and is headquartered in Moncton, Canada.

Arima Genomics Inc. provides tools to help scientists accelerate. The firm offers Arima-HIC kit which helps in understanding of genome structure and sequence. The company was founded by Siddarth Selvara and is headquartered in San Diego, CA.

Stemina Biomarker Discovery, Inc. engages in the development and commercialization of molecular biomarkers to improve drug safety and human health. Its products and services include Cardio quickPredict, devTOX quickPredict, and TOXquickPredict. The company was founded by Elizabeth L. R. Donley and Gabriela G. Cezar in November 2006 and is headquartered in Madison, WI.

Iquity, Inc. is an American company that focuses on accelerating precision medicine. Iquity is based in Nashville. The private company's goal is to deliver the promise of precision medicine by ensuring that the right patient receives the right drug at the right time. The company recognizes that precision medicine is a complex process that requires connected data, mature, scalable data operations, and analytics expertise.

Nexus Dx, Inc. engages in the provision of of a near patient testing system and advanced diagnostic solution. Its offers point-of-care (POC) immunoassay, IB10 analyzer system, and tests for established critical care parameters. The company was founded on January 16, 2009 and is headquartered in San Diego, CA.

Iquity Systems AB is a Swedish company that specializes in accelerating precision medicine. The private company is based in Stockholm, Sweden. The company's focus is on delivering the right patient with the right drug at the right time. The company was founded by Chase Spurlock and he has been the CEO since incorporation.

Thomas Jefferson School of Law provides education services. It include legal courses to students. The company was founded in 1969 and is headquartered in San Diego, CA.

American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021.

Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California.

Cofactor Genomics, Inc. operates as a biotech company that offers services to the life-science, pharmaceutical, agriculture, and biofuels companies. The firm provides human genome projects. The company was founded by Jarret Glasscock, Dave Messina, and Jon Armstrong in 2008 and is headquartered in San Francisco, CA.

Synchrony Bio LLC is a biomedical and life science venture capital firm that aims to achieve superior investor returns in early-stage ventures. The private company is based in St. Louis. The American company aligns seasoned talent, staged investment capital, and process efficiencies to overcome unique challenges faced by medical device and diagnostics ventures, in order to realize significant upside and superior returns. Synchrony Bio's extended network of experts and advisors includes professionals with deep, cross-functional experience and backgrounds. The company was founded by James D. Merselis.

Kypha, Inc. engages in the development of devices and products to monitor and treat inflammatory and autoimmune disorders. Its products include Comp act, RapiPlex, and sample stabilization. The company was founded by Paul K. Olson and Chad M. Stiening on January 14, 2011 and is headquartered in St. Louis, MO.

Abram Scientific, Inc. manufactures medical diagnostic devices. The private company is based in Menlo Park, CA. The company was founded by Abhishek Ramkumar. Edward F. Brennan has been the CEO of the company since 2015.

Biosensia Ltd. develops multiplexing point of care in vitro diagnostics platform. It offers RapiPlex, a point-of-care diagnosis system based on a set of proprietary technologies capable of producing quantitative and qualitative laboratory quality test results. The company was founded by Gareth Redmond and Gabriel Crean in 2009 and is headquartered in Dublin, Ireland.

Micronics, Inc. develops molecular and immuno-hematology diagnostic products. Its products include PanNAT molecular diagnostic system, immunohematology diagnostic products and research & development products. The company was founded in 1996 and is headquartered in Redmond, WA.

YourBio Health, Inc. develops health monitoring products. It is developing an array of products based on the company's proprietary TAP? (Touch Activated Phlebotomy) painless blood collection platform. The company was founded by Richard Rox Anderson, Joerg Lahann, Robert S. Langer Jr., Douglas A. Levinson and Samir Mitragotri in 2008 and is headquartered in Medford, MA.

Electronic Drug Information Systems Solutions LLC develops electronic drug information systems solutions. It operates a platform that gathers, filters, combines, and presents pharmaceutical intelligence. The firm provides data integration, analytics & presentation, forecasting, and project ranking services. The company is headquartered in St. Louis, MO.

Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA.

Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO.

Immunophotonics, Inc. develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine. Its vaccine process under development, inCVAX, is a two injection procedure into one or more selected tumors: The first injection is a needle with an optical fiber (coupled to a laser) that heats selected tumor(s) locally; The second injection is experimental drug product, a proprietary synthesized carbohydrate polymer, that is intended to recruit and activate antigen-presenting cells, potentially triggering a cascade that leads to a systemic anti-tumor immune response. The company was founded by Lu Alleruzzo and Tomas Hode in 2009 and is headquartered in St. Louis, MI.

Covidien Unlimited Co. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. It operates through Medical Devices and U.S. Medical Supplies segments. The Medical Devices segment involves in the distribution of surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. The U.S. Medical Supplies segment includes marketing of nursing care, medical surgical, SharpSafety brand, and original equipment manufacturer (OEM) products. The company was founded in 1967 and is headquartered in Dublin, Ireland.

Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA.